Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308103124> ?p ?o ?g. }
- W4308103124 endingPage "e005632" @default.
- W4308103124 startingPage "e005632" @default.
- W4308103124 abstract "Background Metformin slows tumor growth and progression in vitro, and in combination with chemoradiotherapy, resulted in high overall survival in patients with head and neck cancer squamous cell carcinoma (HNSCC) in our phase 1 clinical trial ( NCT02325401 ). Metformin is also postulated to activate an antitumor immune response. Here, we investigate immunologic effects of metformin on natural killer (NK) and natural killer T cells, including results from two phase I open-label studies in patients with HNSCC treated with metformin ( NCT02325401 , NCT02083692 ). Methods Peripheral blood was collected before and after metformin treatment or from newly diagnosed patients with HNSCC. Peripheral immune cell phenotypes were evaluated using flow cytometry, cytokine expression by ELISA and/or IsoLight, and NK cell-mediated cytotoxicity was determined with a flow-based NK cell cytotoxicity assay (NKCA). Patient tumor immune infiltration before and after metformin treatment was analyzed with immunofluorescence. NK cells were treated with either vehicle or metformin and analyzed by RNA sequencing (RNA-seq). NK cells were then treated with inhibitors of significant pathways determined by RNA-seq and analyzed by NKCA, ELISA, and western blot analyses. Results Increased peripheral NK cell activated populations were observed in patients treated with metformin. NK cell tumor infiltration was enhanced in patients with HNSCC treated with metformin preoperatively. Metformin increased antitumorigenic cytokines ex vivo, including significant increases in perforin. Metformin increased HNSCC NK cell cytotoxicity and inhibited the CXCL1 pathway while stimulating the STAT1 pathway within HNSCC NK cells. Exogenous CXCL1 prevented metformin-enhanced NK cell-mediated cytotoxicity. Metformin-mediated NK cell cytotoxicity was found to be AMP-activated protein kinase independent, but dependent on both mechanistic target of rapamycin and pSTAT1. Conclusions Our data identifies a new role for metformin-mediated immune antitumorigenic function through NK cell-mediated cytotoxicity and downregulation of CXCL1 in HNSCC. These findings will inform future immunomodulating therapies in HNSCC." @default.
- W4308103124 created "2022-11-08" @default.
- W4308103124 creator A5009206625 @default.
- W4308103124 creator A5011589152 @default.
- W4308103124 creator A5013519961 @default.
- W4308103124 creator A5015026678 @default.
- W4308103124 creator A5044665651 @default.
- W4308103124 creator A5047569670 @default.
- W4308103124 creator A5050155318 @default.
- W4308103124 creator A5050693639 @default.
- W4308103124 creator A5057856712 @default.
- W4308103124 creator A5061224094 @default.
- W4308103124 creator A5064686412 @default.
- W4308103124 creator A5075478810 @default.
- W4308103124 creator A5077605764 @default.
- W4308103124 creator A5082352781 @default.
- W4308103124 creator A5084428353 @default.
- W4308103124 date "2022-11-01" @default.
- W4308103124 modified "2023-10-13" @default.
- W4308103124 title "Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition" @default.
- W4308103124 cites W1671560425 @default.
- W4308103124 cites W1953823780 @default.
- W4308103124 cites W1964895626 @default.
- W4308103124 cites W1984564310 @default.
- W4308103124 cites W2007841824 @default.
- W4308103124 cites W2008540208 @default.
- W4308103124 cites W2009219704 @default.
- W4308103124 cites W2021880506 @default.
- W4308103124 cites W2039123767 @default.
- W4308103124 cites W2076541874 @default.
- W4308103124 cites W2087569038 @default.
- W4308103124 cites W2111160461 @default.
- W4308103124 cites W2115415053 @default.
- W4308103124 cites W2143680521 @default.
- W4308103124 cites W2147151262 @default.
- W4308103124 cites W2147589302 @default.
- W4308103124 cites W2150950354 @default.
- W4308103124 cites W2154024364 @default.
- W4308103124 cites W2160571820 @default.
- W4308103124 cites W2164882663 @default.
- W4308103124 cites W2167865797 @default.
- W4308103124 cites W2169456326 @default.
- W4308103124 cites W2169674658 @default.
- W4308103124 cites W2182455706 @default.
- W4308103124 cites W2288651793 @default.
- W4308103124 cites W2323045903 @default.
- W4308103124 cites W2326318129 @default.
- W4308103124 cites W2421713479 @default.
- W4308103124 cites W2471802697 @default.
- W4308103124 cites W2514810684 @default.
- W4308103124 cites W2515812752 @default.
- W4308103124 cites W2560185130 @default.
- W4308103124 cites W2586637063 @default.
- W4308103124 cites W2587277399 @default.
- W4308103124 cites W2596058531 @default.
- W4308103124 cites W2621506639 @default.
- W4308103124 cites W2624060183 @default.
- W4308103124 cites W2783142245 @default.
- W4308103124 cites W2791921059 @default.
- W4308103124 cites W2895186520 @default.
- W4308103124 cites W2901809406 @default.
- W4308103124 cites W2977041418 @default.
- W4308103124 cites W2979760102 @default.
- W4308103124 cites W2981104420 @default.
- W4308103124 cites W3157905732 @default.
- W4308103124 cites W3197518790 @default.
- W4308103124 doi "https://doi.org/10.1136/jitc-2022-005632" @default.
- W4308103124 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36328378" @default.
- W4308103124 hasPublicationYear "2022" @default.
- W4308103124 type Work @default.
- W4308103124 citedByCount "14" @default.
- W4308103124 countsByYear W43081031242022 @default.
- W4308103124 countsByYear W43081031242023 @default.
- W4308103124 crossrefType "journal-article" @default.
- W4308103124 hasAuthorship W4308103124A5009206625 @default.
- W4308103124 hasAuthorship W4308103124A5011589152 @default.
- W4308103124 hasAuthorship W4308103124A5013519961 @default.
- W4308103124 hasAuthorship W4308103124A5015026678 @default.
- W4308103124 hasAuthorship W4308103124A5044665651 @default.
- W4308103124 hasAuthorship W4308103124A5047569670 @default.
- W4308103124 hasAuthorship W4308103124A5050155318 @default.
- W4308103124 hasAuthorship W4308103124A5050693639 @default.
- W4308103124 hasAuthorship W4308103124A5057856712 @default.
- W4308103124 hasAuthorship W4308103124A5061224094 @default.
- W4308103124 hasAuthorship W4308103124A5064686412 @default.
- W4308103124 hasAuthorship W4308103124A5075478810 @default.
- W4308103124 hasAuthorship W4308103124A5077605764 @default.
- W4308103124 hasAuthorship W4308103124A5082352781 @default.
- W4308103124 hasAuthorship W4308103124A5084428353 @default.
- W4308103124 hasBestOaLocation W43081031241 @default.
- W4308103124 hasConcept C109316439 @default.
- W4308103124 hasConcept C121608353 @default.
- W4308103124 hasConcept C126322002 @default.
- W4308103124 hasConcept C13373296 @default.
- W4308103124 hasConcept C167672396 @default.
- W4308103124 hasConcept C183193105 @default.
- W4308103124 hasConcept C202751555 @default.
- W4308103124 hasConcept C203014093 @default.